Lunsumio 1 mg and 30 mg concentrate for solution for infusion

Company:
Roche Registration GmbH
Status:
No Recent Update
Legal Category:
Product subject to medical prescription which may not be renewed (A)
Active Ingredient(s):
Mosunetuzumab
This medicinal product is subject to additional monitoring.
*Additional information is available within the SPC or upon request to the company

Licence number

Strength

ATC code

Dosage form

EU/1/22/1649/001

1 mg/1 mL

L01,L01FX25

Concentrate for solution for infusion

EU/1/22/1649/002

30 mg/30 mL

L01,L01FX25

Concentrate for solution for infusion